Wegovy is an injectable (sub-cutaneous) prescription weight loss medicine that is indicated for people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael ...

SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep dives into clinical, social, and ...

New data released by the Centers for Disease Control and Prevention (CDC) has provided insight into the prevalence of obesity across the United States. The figures, initially from the 2023 Adult ...

Obesity prevention strategies often focus on diet, but eating behaviors also play a key role. In a recent study, researchers from Japan investigated factors influencing meal duration, including sex ...

Around 40% of adults in the U.S. are obese, new data from the Centers for Disease Control and Prevention suggests — marking the first time in over a decade that the nation's obesity rate has not ...

Severe obesity throughout the U.S. continues to rise, a new study from the U.S. Centers of Disease Control and Prevention (CDC) shows. On Tuesday, the U.S. CDC published a report on the prevalence of ...

Obesity is an epidemic in the America. Four in 10 U.S. adults fit the medical definition of having obesity, which puts them at risk for serious health problems, including diabetes, heart disease and ...

Forecasts indicate a drastic increase in US obesity rates in the next 25 years, emphasizing the need for comprehensive public health strategies. For reference, the total US population is 337 million ...

New genetic research shows a simple genetic test can predict who’s most at risk for obesity, offering hope for early prevention, but also raises tough questions about genetic fairness and healthcare ...